Preliminary results from the US Food and Drug Administration's (FDA's) mandated postmarket surveillance studies of duodenoscopes show "higher-than-expected" contamination rates after reprocessing, according to an article on the Medscape website.
The FDA said 3 percent of properly collected samples tested positive for more than 100 colony-forming units of "low-concern" organisms.
These organism are unlikely to cause serious infections but are, nevertheless, an indication of a "reprocessing failure."
An additional 3 percent of properly collected samples tested positive for "high-concern" bacteria that are more often associated with disease.
Designing Hospitals for Wellness
Baptist Health Announces New Cancer Care Center in Key West
Waco Family Medicine Achieves Savings and Bold Design with Wood Selections
Alleged Ransomware Administrator Extradited from South Korea
Design Plans Unveiled for New Intermountain St. Vincent Regional Hospital